Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKesson
US Army
Chinese Patent Office
Boehringer Ingelheim
Accenture
Healthtrust
Fish and Richardson
McKinsey

Generated: February 15, 2019

DrugPatentWatch Database Preview

Hydralazine hydrochloride; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydralazine hydrochloride; hydrochlorothiazide and what is the scope of hydralazine hydrochloride; hydrochlorothiazide patent protection?

Hydralazine hydrochloride; hydrochlorothiazide is the generic ingredient in twenty-one branded drugs marketed by Novartis, Par Pharm, Solvay, Superpharm, Watson Labs, Ivax Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Sandoz, Sun Pharm Industries, and Lederle, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for hydralazine hydrochloride; hydrochlorothiazide.

Summary for hydralazine hydrochloride; hydrochlorothiazide
US Patents:0
Tradenames:21
Applicants:12
NDAs:36
Drug Master File Entries: 21
Bulk Api Vendors: 1
Clinical Trials: 3
DailyMed Link:hydralazine hydrochloride; hydrochlorothiazide at DailyMed
Synonyms for hydralazine hydrochloride; hydrochlorothiazide
C8H8N4.C7H8ClN3O4S2.HCl
LS-178474
SCHEMBL9374288

US Patents and Regulatory Information for hydralazine hydrochloride; hydrochlorothiazide

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis SER-AP-ES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 012193-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms HYDROSERPINE PLUS (R-H-H) hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 083877-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs HYDRALAZINE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide TABLET;ORAL 085827-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085771-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Superpharm HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 089201-001 Feb 9, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087085-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Medtronic
QuintilesIMS
Harvard Business School
Dow
Healthtrust
Farmers Insurance
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: